Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 2,079 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
1A
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
RR
THE CONAFAY GROUP, LLC for BRIGHT PATH LABORATORIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona
Medical/Disease Research/Clinical Labs
View →
RR
CORNERSTONE GOVERNMENT AFFAIRS, INC. for LILA SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Budget/Appropriations, Defense, Energy/Nuclear, Health Issues
View →
RR
CAPITOL COUNSEL LLC for BRISTOL-MYERS SQUIBB
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
RR
CHECKMATE GOVERNMENT RELATIONS for BIOHAVEN LTD.
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut
Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
RR
MARBLE ARCH for LILA SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Budget/Appropriations, Defense, Energy/Nuclear, Health Issues
View →
Q4
THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $16,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
RR
INVARIANT LLC for ROSWELL PARK COMPREHENSIVE CANCER CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · New York
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Veterans
View →
RR
CONTINENTAL STRATEGY, LLC for IMMIX BIOPHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California
Medical/Disease Research/Clinical Labs
View →
RR
CAPITOL COUNSEL LLC for MADRIGAL PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
OCAL LOBBYING GROUP for BR.MANNESMAN TECHNOLOGY
4th Quarter (Oct 1 - Dec 31) 2025
Medical/Disease Research/Clinical Labs
View →
Q4
OCAL LOBBYING GROUP for SAMERA S.A.
4th Quarter (Oct 1 - Dec 31) 2025
Medical/Disease Research/Clinical Labs
View →
Q4
INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues
View →
RR
IKON PUBLIC AFFAIRS for WISTAR INSTITUTE
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania
Medical/Disease Research/Clinical Labs
View →
RR
CORNERSTONE GOVERNMENT AFFAIRS, INC. for RADIATRIC, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Washington
Medical/Disease Research/Clinical Labs, Science/Technology, Budget/Appropriations, Defense
View →
RR
CROSSROADS STRATEGIES, LLC for RESEARCH!AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia
Budget/Appropriations, Medical/Disease Research/Clinical Labs, Science/Technology
View →
Q4
AMERICAN GASTROENTEROLOGICAL ASSOCIATION for AMERICAN GASTROENTEROLOGICAL ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
AMERICAN SOCIETY FOR CLINICAL PATHOLOGY for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Labor Issues/Antitrust/Workplace, Medicare/Medicaid
View →
RR
ADAPTIVE GOVERNMENT RELATIONS for SEATTLE CHILDREN'S
1st Quarter (Jan 1 - Mar 31) 2026 · Washington
Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs
View →
4A
ST. BALDRICK'S FOUNDATION for ST. BALDRICK'S FOUNDATION
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medical/Disease Research/Clinical Labs, Health Issues
View →
Q4
ATLAS ADVOCACY for BRIOTECH INC
4th Quarter (Oct 1 - Dec 31) 2025 · Wisconsin · House · Senate
Medical/Disease Research/Clinical Labs
View →
4A
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) for PPLA
4th Quarter (Oct 1 - Dec 31) 2025 · New York · $31,250.00 income
Medical/Disease Research/Clinical Labs
View →
Q4
AWSOM ASSOC for HOLY NAME MED CTR
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $5,000.00 income
Medical/Disease Research/Clinical Labs
View →
RR
DHI CONSULTING GROUP, LLC for NOW START COMMUNITY FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2026 · Texas
Consumer Issues/Safety/Products, Defense, Energy/Nuclear, Financial Institutions/Investments/Securities
View →
Q4
JACOBS & ASSOCIATES, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) for PPLA
4th Quarter (Oct 1 - Dec 31) 2025 · New York · $31,250.00 income
Medical/Disease Research/Clinical Labs
View →
Previous Page 29 of 84 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem